186 related articles for article (PubMed ID: 28118537)
1. Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus.
Werth VP; Fiorentino D; Sullivan BA; Boedigheimer MJ; Chiu K; Wang C; Arnold GE; Damore MA; Bigler J; Welcher AA; Russell CB; Martin DA; Chung JB
Arthritis Rheumatol; 2017 May; 69(5):1028-1034. PubMed ID: 28118537
[TBL] [Abstract][Full Text] [Related]
2. Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus.
Welcher AA; Boedigheimer M; Kivitz AJ; Amoura Z; Buyon J; Rudinskaya A; Latinis K; Chiu K; Oliner KS; Damore MA; Arnold GE; Sohn W; Chirmule N; Goyal L; Banfield C; Chung JB
Arthritis Rheumatol; 2015 Oct; 67(10):2713-22. PubMed ID: 26138472
[TBL] [Abstract][Full Text] [Related]
3. Brief Report: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis.
Cheng LE; Amoura Z; Cheah B; Hiepe F; Sullivan BA; Zhou L; Arnold GE; Tsuji WH; Merrill JT; Chung JB
Arthritis Rheumatol; 2018 Jul; 70(7):1071-1076. PubMed ID: 29513931
[TBL] [Abstract][Full Text] [Related]
4. Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study.
Barikbin B; Givrad S; Yousefi M; Eskandari F
Clin Exp Dermatol; 2009 Oct; 34(7):776-80. PubMed ID: 19456797
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of R-salbutamol for topical treatment of discoid lupus erythematosus.
Jemec GB; Ullman S; Goodfield M; Bygum A; Olesen AB; Berth-Jones J; Nyberg F; Cramers M; Faergemann J; Andersen P; Kuhn A; Ruzicka T
Br J Dermatol; 2009 Dec; 161(6):1365-70. PubMed ID: 19681862
[TBL] [Abstract][Full Text] [Related]
6. Detection of type 1 cytokines in discoid lupus erythematosus.
Toro JR; Finlay D; Dou X; Zheng SC; LeBoit PE; Connolly MK
Arch Dermatol; 2000 Dec; 136(12):1497-501. PubMed ID: 11115160
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
Drucker AM; Su J; Mussani F; Siddha SK; Gladman DD; Urowitz MB
Lupus; 2016 Apr; 25(4):376-81. PubMed ID: 26453664
[TBL] [Abstract][Full Text] [Related]
8. A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index.
Pothinamthong P; Janjumratsang P
J Med Assoc Thai; 2012 Jul; 95(7):933-40. PubMed ID: 22919989
[TBL] [Abstract][Full Text] [Related]
9. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
Merrill JT; Wallace DJ; Petri M; Kirou KA; Yao Y; White WI; Robbie G; Levin R; Berney SM; Chindalore V; Olsen N; Richman L; Le C; Jallal B; White B;
Ann Rheum Dis; 2011 Nov; 70(11):1905-13. PubMed ID: 21798883
[TBL] [Abstract][Full Text] [Related]
10. Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis.
Boedigheimer MJ; Martin DA; Amoura Z; Sánchez-Guerrero J; Romero-Diaz J; Kivitz A; Aranow C; Chan TM; Chong YB; Chiu K; Wang C; Sohn W; Arnold GE; Damore MA; Welcher AA; Sullivan BA; Kotzin BL; Chung JB
Lupus Sci Med; 2017; 4(1):e000226. PubMed ID: 29018537
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic relationship of AMG 811, an anti-IFN-γ IgG1 monoclonal antibody, in patients with systemic lupus erythematosus.
Chen P; Vu T; Narayanan A; Sohn W; Wang J; Boedigheimer M; Welcher AA; Sullivan B; Martin DA; Ruixo JJ; Ma P
Pharm Res; 2015 Feb; 32(2):640-53. PubMed ID: 25213774
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms.
Domingo S; Solé C; Moliné T; Ferrer B; Ordi-Ros J; Cortés-Hernández J
Dermatology; 2020; 236(5):467-476. PubMed ID: 32659758
[TBL] [Abstract][Full Text] [Related]
13. Site-specific analysis of inflammatory markers in discoid lupus erythematosus skin.
Thorpe RB; Gray A; Kumar KR; Susa JS; Chong BF
ScientificWorldJournal; 2014; 2014():925805. PubMed ID: 24744689
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus.
Sugano M; Shintani Y; Kobayashi K; Sakakibara N; Isomura I; Morita A
J Dermatol; 2006 Dec; 33(12):887-91. PubMed ID: 17169097
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma.
Corren J; Busse W; Meltzer EO; Mansfield L; Bensch G; Fahrenholz J; Wenzel SE; Chon Y; Dunn M; Weng HH; Lin SL
Am J Respir Crit Care Med; 2010 Apr; 181(8):788-96. PubMed ID: 20056900
[TBL] [Abstract][Full Text] [Related]
16. Pulsed-dye laser as an adjuvant treatment for discoid lupus erythematosus: a randomized, controlled trial.
Rerknimitr P; Tekacharin N; Panchaprateep R; Wititsuwannakul J; Tangtanatakul P; Hirankarn N; Asawanonda P
J Dermatolog Treat; 2019 Feb; 30(1):81-86. PubMed ID: 29676592
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the incidence of discoid lupus erythematosus in patients with systemic lupus erythematosus and its relationship to disease activity.
Saghafi M; Hashemzadeh K; Sedighi S; Yazdanpanah MJ; Rezaieyazdi Z; Sahebari M; Esmaily H
J Cutan Med Surg; 2014 Oct; 18(5):316-9. PubMed ID: 25186992
[TBL] [Abstract][Full Text] [Related]
18. Acitretin treatment in antimalarial-refractory/intolerant discoid lupus erythematosus: A prospective, open-label, uncontrolled study.
Laosakul K; Chiewchanvit S; Chuamanochan M; Tovanabutra N
Lupus; 2022 Apr; 31(5):575-581. PubMed ID: 35306922
[TBL] [Abstract][Full Text] [Related]
19. Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus.
Tlacuilo-Parra A; Guevara-Gutiérrez E; Gutiérrez-Murillo F; Soto-Ortiz A; Barba-Gómez F; Hernández-Torres M; Salazar-Páramo M
Rheumatology (Oxford); 2005 Dec; 44(12):1564-8. PubMed ID: 16159951
[TBL] [Abstract][Full Text] [Related]
20. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
